长期使用苯妥英钠致进行性呼吸困难
一例54岁南非男性,既往2型糖尿病、癫痫、OSA及潜伏性结核,因数月进行性呼吸困难就诊,长期服用苯妥英钠300 mg/日控制癫痫22年。门诊按社区获得性肺炎予左氧氟沙星无效,COVID-19检测阴性。病例提示长期苯妥英钠可能是进行性呼吸困难的原因之一。
要点
- 长期苯妥英钠治疗者出现进行性呼吸困难需考虑药物相关肺损伤。
- 常规肺炎治疗无效且感染证据不足时,应排查药物性病因。
- 详细用药史对呼吸科不明原因呼吸困难的鉴别诊断至关重要。
核心结论
- 长期使用苯妥英钠可能是进行性呼吸困难的原因。
研究设计与样本
- 单例病例报告:54岁南非男性,既往2型糖尿病、癫痫、OSA及潜伏性结核。
主要发现
- 患者因数月进行性呼吸困难就诊,伴偶发干咳和乏力。
- 门诊按社区获得性肺炎予左氧氟沙星无效,COVID-19检测阴性。
- 患者长期服用苯妥英钠300 mg/日控制复杂部分性癫痫22年。
临床怎么用
- 对长期服用苯妥英钠的呼吸困难患者,应将药物性肺损伤纳入鉴别诊断。
局限性
- 单例病例报告,无法确立因果关系或评估发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 54-year-old South African man with a medical history of type 2 diabetes mellitus, seizure disorder, OSA, and latent TB presented to the ER with gradually progressive dyspnea over months. He also reported occasional dry cough and fatigue at presentation but denied fever, chills, chest pain, leg swelling, palpitations, or lightheadedness. He was treated with a course of levofloxacin for presumed community-acquired pneumonia as an outpatient without improvement and had tested negative for COVID-19. He denied occupational or environmental exposures or sick contacts, though he had traveled back to South Africa 1 year before presentation. He had complex partial seizures for the past 22 years, which had been well controlled on phenytoin (300 mg daily). His other home medications included dulaglutide, sertraline, and atorvastatin and had no recent changes. He quit smoking 30 years ago after smoking one pack per day for 10 years.
引用
- Walker, Rupal, Jani, et al. Longstanding Phenytoin Use as a Cause of Progressive Dyspnea. Chest. 2022. PMID: 35131079. doi:10.1016/j.chest.2021.08.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。